GLOW blends BPC-157, TB-500 and GHK-Cu. What's in a vial, per-draw math by label, GLOW vs KLOW vs Wolverine, skin vs recovery claims, and the evidence gaps.
PeptIQ Team
Peptide Research & Education
PeptIQ app
Log this BPC-157 stack in PeptIQ
Track every compound, timing, and dose in one protocol, on web or mobile.
Under 25? Talk to a licensed clinician and get baseline labs before starting anything. Why we say this · Labs checklist
What Is the GLOW Peptide?
GLOW is a pre-mixed blend of three peptides: BPC-157, TB-500 and GHK-Cu. It's marketed for recovery plus skin, hair and "glow" benefits, and it's searched alongside KLOW, its four-peptide cousin. None of the three components is FDA-approved, and nobody has studied the blend as a whole in a clinical trial.
Don't confuse it with the cosmetic "glow peptide" serums and creams from skincare brands. Those are topical cosmetics, which are a different category of product from injectable research-peptide blends.
This guide explains the components and the math. It isn't dosing advice. Talk with a licensed clinician before using any peptide.
What's in a GLOW Vial
Component
What it is
Main research context
BPC-157
A synthetic 15-amino-acid peptide originally isolated from gastric juice
Tendon, muscle and gut repair (mostly animal studies)
TB-500
A synthetic peptide marketed as related to thymosin beta-4
Cell migration and wound repair (Tβ4 research)
GHK-Cu
A naturally occurring copper-binding tripeptide
Skin, wound healing and gene-expression research, much of it topical or lab-based
Ratios vary by seller. Some GLOW labels list much more GHK-Cu than the other two. Others split the vial evenly. Always work from your own vial's label.
GLOW Dosage Chart: What Each Draw Contains
A blend can't be split. Every draw contains all three peptides in the label's fixed ratio. For each component (U-100 syringe, 10 units = 0.1 mL):
mg per 10 units = (mg of that component ÷ mL of water) × 0.1
Example label B: even split, about 3.33 mg of each (10 mg total)
Water
Each component / 10 units
2 mL
0.167 mg (167 mcg)
3 mL
0.111 mg (111 mcg)
5 mL
0.067 mg (67 mcg)
The same "10 units" gives very different amounts depending on the label. With label A, 10 units holds 15 times more GHK-Cu than with label B at the same water volume. That's the biggest source of GLOW confusion online.
These tables are arithmetic, not a schedule. There's no evidence-based "GLOW frequency chart," because no trials have tested the blend. Use the GLOW blend calculator with your own label.
GLOW vs KLOW vs Wolverine
Blend
BPC-157
TB-500
GHK-Cu
KPV
Wolverine
✓
✓
GLOW
✓
✓
✓
KLOW
✓
✓
✓
✓
GLOW vs KLOW: KLOW adds KPV, a three-amino-acid peptide studied for inflammation, mostly in cell and mouse models of colitis. See the KLOW guide and KLOW calculator.
GLOW vs Wolverine: Wolverine is just BPC-157 + TB-500, without GHK-Cu. See the Wolverine stack guide.
Adding components doesn't add proven benefit. It adds more variables, and if you react to a blend, you can't tell which component caused it.
"Glow" Skin Claims vs the Evidence
GHK-Cu is where the "glow" branding comes from. A widely cited 2018 review, written by researchers at a skin-care R&D company, describes GHK's tissue-repair effects in skin, connective tissue, bone, liver and stomach lining, along with gene-expression data. Much of that work is lab, animal or topical research. Results from copper-peptide creams don't automatically carry over to injecting a blend. For BPC-157 and TB-500, a 2026 UCLA scoping review found that two-thirds of publications were animal studies, and human data showed "modest improvements at best."
Bottom line: there's plausible biology and very little human evidence, and no studies at all of the GLOW combination.
Safety and Regulatory Status
No component is FDA-approved for injection.
FDA has published concerns about compounded injectable GHK-Cu (possible immune reactions linked to aggregation) and BPC-157 (immunogenicity and limited safety data).
July 2026 FDA advisory vote: the compounding committee narrowly recommended BPC-157 and TB-500 (plus KPV) for the 503A compounding list. That's not approval, and FDA still has to act. GHK-Cu wasn't part of that vote.
"Research use only" vials marketed for human use draw FDA warning letters.
If a clinician is guiding you, log the blend as one vial with three components so your history shows how much of each you actually used. PeptIQ supports multi-component vials, injection-site rotation and check-ins for skin, joints and recovery. Photos are especially useful for skin goals. Do the vial math on the web calculator, then track everything in the app.
Frequently Asked Questions
Q: What is the GLOW peptide?
A: A blend of BPC-157, TB-500 and GHK-Cu, usually sold as a single vial. It's different from cosmetic "glow peptide" skincare.
Q: What's the GLOW peptide dosage?
A: There's no clinically established dose for the blend, and none of the components is approved. The tables above show how much of each component is in a draw for example labels. Dosing decisions belong with a licensed clinician.
Q: GLOW vs KLOW: what's the difference?
A: KLOW is GLOW plus KPV, so four peptides instead of three.
Q: Is GLOW the same as Wolverine?
A: No. Wolverine is only BPC-157 + TB-500. GLOW adds GHK-Cu.
Q: Why do GLOW dosage charts online disagree?
A: Because vial labels differ. A 70 mg vial heavy on GHK-Cu and a 10 mg even-split vial give very different amounts per unit.
This article is educational content from PeptIQ. It is not medical advice. Talk with a licensed clinician before starting, stopping, or changing any peptide, medication, or injection practice.